Candriam S.C.A. United Therapeutics Corp Transaction History
Candriam S.C.A.
- $15.6 Billion
- Q1 2025
A detailed history of Candriam S.C.A. transactions in United Therapeutics Corp stock. As of the latest transaction made, Candriam S.C.A. holds 79,213 shares of UTHR stock, worth $25.3 Million. This represents 0.16% of its overall portfolio holdings.
Number of Shares
79,213
Previous 74,607
6.17%
Holding current value
$25.3 Million
Previous $26.3 Million
7.24%
% of portfolio
0.16%
Previous 0.16%
Shares
13 transactions
Others Institutions Holding UTHR
# of Institutions
733Shares Held
43.6MCall Options Held
124KPut Options Held
122K-
Black Rock Inc. New York, NY5.47MShares$1.75 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.46MShares$1.42 Billion0.03% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.68MShares$855 Million13.34% of portfolio
-
State Street Corp Boston, MA2.23MShares$713 Million0.03% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.11MShares$674 Million1.04% of portfolio
About UNITED THERAPEUTICS Corp
- Ticker UTHR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,516,300
- Market Cap $14.6B
- Description
- United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...